These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 18758699

  • 1. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol.
    Yilmaz MB, Erdem A, Yalta K, Turgut OO, Yilmaz A, Tandogan I.
    Adv Ther; 2008 Sep; 25(9):871-83. PubMed ID: 18758699
    [Abstract] [Full Text] [Related]

  • 2. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A, Uzunlulu M, Yorulmaz E, Yalçin Y, Hekim N, Fici F.
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA.
    Heitmann J, Greulich T, Reinke C, Koehler U, Vogelmeier C, Becker HF, Schmidt AC, Canisius S.
    Curr Med Res Opin; 2010 Aug; 26(8):1925-32. PubMed ID: 20560730
    [Abstract] [Full Text] [Related]

  • 4. Sleep quality in patients with hypertension: additional negative effect of drug therapy.
    Yontar OC, Erdem A, Yilmaz MB.
    Sleep Med; 2009 Dec; 10(10):1168; author reply 1168-9. PubMed ID: 19467925
    [No Abstract] [Full Text] [Related]

  • 5. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH, Hainer JW, Sugg J, M-FACT Study Group.
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [Abstract] [Full Text] [Related]

  • 6. Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients.
    Cleophas TJ, Agrawal R, Lichtenthal A, Mäkel W, Fici F.
    Am J Ther; 2006 Apr; 13(3):192-7. PubMed ID: 16772759
    [Abstract] [Full Text] [Related]

  • 7. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.
    Sen N, Tavil Y, Erdamar H, Yazici HU, Cakir E, Akgül EO, Bilgi C, Erbil MK, Poyraz F, Okyay K, Turfan M, Cemri M.
    Anadolu Kardiyol Derg; 2009 Oct; 9(5):371-9. PubMed ID: 19819787
    [Abstract] [Full Text] [Related]

  • 8. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients.
    Doumas M, Tsakiris A, Douma S, Grigorakis A, Papadopoulos A, Hounta A, Tsiodras S, Dimitriou D, Giamarellou H.
    Asian J Androl; 2006 Mar; 8(2):177-82. PubMed ID: 16491268
    [Abstract] [Full Text] [Related]

  • 9. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R, Lichtenthal A, Wöhling H, Graf C, Brixius K.
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [Abstract] [Full Text] [Related]

  • 10. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J, Faülhaber HD.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
    [Abstract] [Full Text] [Related]

  • 11. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA.
    Am J Hypertens; 2005 Dec 27; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [Abstract] [Full Text] [Related]

  • 12. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
    Van Bortel LM, Breed JG, Joosten J, Kragten JA, Lustermans FA, Mooij JM.
    J Cardiovasc Pharmacol; 1993 Jun 27; 21(6):856-62. PubMed ID: 7687708
    [Abstract] [Full Text] [Related]

  • 13. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J, Faulhaber HD.
    Praxis (Bern 1994); 2001 Mar 15; 90(11):435-41. PubMed ID: 11293936
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
    Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH.
    Clin Exp Pharmacol Physiol; 2007 Apr 15; 34(4):327-31. PubMed ID: 17324145
    [Abstract] [Full Text] [Related]

  • 15. EVOLVE (nebivolol evaluation for efficacy and safety in the treatment of hypertension) postmarketing surveillance study.
    Faruqui AA.
    J Indian Med Assoc; 2007 May 15; 105(5):272, 274, 276-7. PubMed ID: 17915798
    [Abstract] [Full Text] [Related]

  • 16. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol.
    Celik T, Yuksel UC, Iyisoy A, Kursaklioglu H, Ozcan O, Kilic S, Ozmen N, Isik E.
    Int J Cardiol; 2007 Mar 20; 116(2):206-11. PubMed ID: 16822563
    [Abstract] [Full Text] [Related]

  • 17. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar 20; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients.
    Celik T, Iyisoy A, Kursaklioglu H, Kardesoglu E, Kilic S, Turhan H, Yilmaz MI, Ozcan O, Yaman H, Isik E, Fici F.
    J Hypertens; 2006 Mar 20; 24(3):591-6. PubMed ID: 16467663
    [Abstract] [Full Text] [Related]

  • 19. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
    Espinola-Klein C, Weisser G, Jagodzinski A, Savvidis S, Warnholtz A, Ostad MA, Gori T, Munzel T.
    Hypertension; 2011 Aug 20; 58(2):148-54. PubMed ID: 21646599
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I-II hypertension.
    Germino FW, Lin Y, Pejović V, Bowen L.
    Ther Adv Cardiovasc Dis; 2012 Oct 20; 6(5):185-99. PubMed ID: 23008339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.